0000000000618723

AUTHOR

A. Bucci

showing 2 related works from this author

Efficacy, safety and tolerability of combined low-dose simvastatin-fenofibrate treatment in primary mixed hyperlipidaemia.

2007

In order to assess the long-term (12 months) efficacy and safety of fenofibrate administered with simvastatin in the treatment of primary mixed hyperlipidaemia, we conducted a study that compared increasing dosages of these drugs in subgroups of men and women belonging to a clinical sample of outpatients. This was an open study carried out in patients with primary mixed hyperlipidaemia (lipoprotein phenotype IIb) who needed a combined therapeutic approach because of their poor response to a single-drug regimen with an HMG-CoA reductase inhibitor (simvastatin). Thus, a fibrate (fenofibrate) was added to the therapy. The study lasted 12 months. Forty-five patients (mean age: 58.9 ± 11.3 years…

medicine.medical_specialtyFenofibrateDosemedicine.drug_classbusiness.industrynutritional and metabolic diseasesGeneral MedicineFibratePharmacologyGastroenterologyDiscontinuationRegimenTolerabilitySimvastatinInternal medicinemedicinelipids (amino acids peptides and proteins)Pharmacology (medical)Adverse effectbusinessmedicine.drugClinical drug investigation
researchProduct

Vascular risk factors in glaucoma: The results of a national survey

2007

Background The role of vascular risk factors in glaucoma is still being debated. To assess the importance of vascular risk factors in patients with primary open-angle glaucoma (POAG), data from the medical history of 2,879 POAG patients and 973 age-matched controls were collected and analyzed. Methods Design: observational survey. Setting: 35 Italian academic centers. Study population: POAG patients and age-matched controls. In order to reduce bias consecutive patients were included. Observation procedures: data concerning vascular risk factors were collected for all patients with a detailed questionnaire. A complete ophthalmological examination with assessment of intraocular pressure (IOP)…

Malemedicine.medical_specialtyIntraocular pressuregenetic structuresDiastoleGlaucomaBlood PressureGlaucoma; Risk factors; Survey; Aged; Blood Pressure; Cardiovascular Diseases; Family Health; Female; Glaucoma Open-Angle; Humans; Intraocular Pressure; Italy; Male; Risk Factors; Surveys and Questionnaires; Visual Fields; Health Surveys; Ophthalmology; Sensory Systems; Cellular and Molecular NeuroscienceNOCellular and Molecular NeuroscienceGlaucoma; Risk factors; Survey; Aged; Blood Pressure; Cardiovascular Diseases; Family Health; Female; Glaucoma Open-Angle; Humans; Intraocular Pressure; Italy; Male; Risk Factors; Surveys and Questionnaires; Visual Fields; Health Surveys; OphthalmologySettore MED/30OphthalmologySurveys and QuestionnairesmedicineHumansMedical historyFamily historyGlaucoma; Risk factors; Survey;SurveyIntraocular PressureAgedFamily HealthSettore MED/30 - Malattie Apparato Visivobusiness.industryIntraocular pressure GlaucomaGlaucomaOdds ratiomedicine.diseaseHealth Surveyseye diseasesSensory SystemsOphthalmologyBlood pressureOpen-AngleRisk factorsItalyCardiovascular DiseasesPopulation studyFemalesense organsVisual FieldsbusinessGlaucoma Open-Angle
researchProduct